Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

New & experimental hepatitis C treatment

New AbbVie hepatitis C combination cures 99% of people with cirrhosis

News
21 April 2017
Hepatitis C treatment

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

News
21 April 2017
Hepatitis C treatment

European HCV treatment access survey shows big variations in eligibility

News
20 April 2017
Hepatitis C treatment

Curing hepatitis C reduces cardiovascular risk

News
20 April 2017
Hepatitis C treatment

Hepatitis C treatment can be provided successfully at syringe programme sites

News
19 April 2017
Pharmaceutical industry

Top 10 Pharmaceutical Companies 2017

Editor's pick
LinkedIn
18 April 2017
Access to healthcare

Hepatitis drug patent application opposed

Editor's pick
Bangkok Post
12 April 2017
Hepatitis C treatment

WHO prequalifies first generic active ingredient for hepatitis C medicines

Editor's pick
World Health Organization
5 April 2017
Hepatitis C treatment

Scale up of hepatitis C treatment possible as Brazil rejects patent on key drug

Editor's pick
MSF
3 April 2017
Hepatitis C treatment

France Reaches Agreement With Gilead To Drop Prices Of Hepatitis C Treatment

Editor's pick
Intellectual Property Watch
3 April 2017
Hepatitis C treatment

New Report Lays Plan to Eliminate 90,000 Hepatitis B and C Deaths by 2030

Editor's pick
National Academies of Science. Technology and Engineering
29 March 2017
Hepatitis C treatment

The 2017 Hepatitis C Community Summit – a key step on the road to elimination

Editor's pick
BMC Blogs Network (blog)
27 March 2017
Access to healthcare

Gilead hepatitis C drug patent faces European challenge

Editor's pick
Reuters
27 March 2017
Access to healthcare

Pharma could take NHS England to court over new delaying tactics

Editor's pick
PharmaPhorum
27 March 2017
Hepatitis C treatment

Optimism About HCV Treatment Comes With Caveats

Editor's pick
Medscape
22 March 2017
Access to healthcare

Drugs costing 8p a day could be hit by 'devastating' NHS rationing plan

Editor's pick
Telegraph
16 March 2017
Hepatitis C treatment

Malaysia: MOH to propose importing generic Hepatitis C meds

Editor's pick
Malay Mail Online
14 March 2017
Hepatitis & HIV

Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals

News
10 March 2017
Hepatitis & HIV

DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants

News
8 March 2017
Hepatitis C treatment

Hepatitis C patients and nurses highlight impact of the virus in new reports

Editor's pick
Hepatitis C Trust
7 March 2017
Hepatitis C treatment

'I bought hepatitis C cure from Bangladesh'

Editor's pick
BBC Health
2 March 2017
Access to healthcare

Hepatitis C drugs re-energize global fight over patents

Editor's pick
Nature
1 March 2017
Hepatitis C treatment

Ukraine signs amicable agreement with Gilead on hepatitis C drug

Editor's pick
Interfax Ukraine
27 February 2017
Hepatitis C treatment

Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

News
27 February 2017